Protecting Vision in Aging Eyes 

A Fribourg-Based Therapy for Macular Degeneration

Every year, millions of older adults around the world lose their vision due to age-related macular degeneration (AMD), a disease that slowly damages the central part of the retina needed for reading, recognizing faces, and maintaining independence. Effective treatments for the most common dry form of AMD are still lacking.

This project aims to translate a novel scientific discovery into a treatment that will contribute to preserving vision and quality of life for older adults throughout Switzerland and beyond national borders.

The research group led by Professor Patricia Boya has recently discovered and patented a new group of active compounds. These active compounds have demonstrated vision rescue in a mouse model of retinal degeneration and protection in an in vitro AMD model. Based on these very promising results, our goal now is to advance this discovery to a crucial stage: testing the activity of these compounds in models that are much closer to the human eye.

Your support will allow us to translate our scientific discovery into a therapy that safeguards vision and quality of life for older adults throughout Switzerland and beyond.